GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
GE HealthCare has today announced, at the European Congress of Radiology (ECR) in Vienna, Austria, the completion of Phase I subject recruitment in its early clinical development program for a first-of-its-kind manganese-based macrocyclic magnetic resonance imaging (MRI) contrast agent. Typically, MRI agents – used to enhance visualization of abnormal structures or lesions and to aid differentiation between healthy and pathological tissue – are gadolinium-based. This manganese-based agent could broaden GE HealthCare’s portfolio of MRI contrast agents available to radiologists, providing a potential alternative in light of perceived concerns relating to gadolinium retention.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230228006355/en/
GE HealthCare is innovating in contrast media (Photo: Business Wire)
The macrocyclic, extra-cellular – or general-purpose – manganese-based contrast agent has comparable relaxivity - the ability of a contrast agent to enhance signal intensity during an MRI scan - and is expected to be diagnostically similar to current gadolinium-based contrast agents (GBCAs). Unlike gadolinium, manganese is endogenous, meaning that it is a trace element that is naturally occurring in and efficiently eliminated from the body. Along with its magnetic properties, this makes a manganese-based agent a viable alternative to gadolinium. In addition, a non-gadolinium agent could help limit the potential impact of post-patient excreted gadolinium in the environment.
The clinical trial, based at the clinical research unit at the Oslo University Hospital, Rikshospitalet, Norway, and overseen by Lead Investigator, Hasse K. Zaré, aims to investigate the safety profile and how this injectable manganese contrast agent is eliminated from the body in healthy volunteers. Previous manganese-based MRI agents have been reliant on a ‘free manganese’ release mechanism for their imaging efficacy. This novel investigational agent is tightly bound to the chelate, in a macrocyclic cage-like structure, so it is rapidly eliminated from - rather than actively released into - the body.
Dr Paul Evans, Head of Global R&D at GE HealthCare’s Pharmaceutical Diagnostics unit, said: “For many years we’ve been committed to investing in, and bringing to market, products to help solve some of radiology’s biggest challenges and unmet needs. This manganese-based MRI agent is one of a number of novel agents we have at various stages of development in our innovation pipeline, all of which aim to give practitioners more choice in delivering precision care for their patients.”
GE HealthCare’s Pharmaceutical Diagnostics unit is a global leader in imaging agents used to support around 100 million procedures per year globally, equivalent to three patient procedures every second. For more than 40 years, GE imaging agents have been routinely used across MRI, X-ray/CT and ultrasound to enhance clinical images and support diagnosis.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.
Follow us on Facebook, LinkedIn, Twitter, and Insights for the latest news, or visit our website www.gehealthcare.com for more information.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006355/en/
GE HealthCare Media:
M +3364 700 8271
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Laserfiche Recognized as a Strong Performer in Independent Analyst Report on Content Platform Providers24.3.2023 21:38:00 EET | Press release
Laserfiche — the leading SaaS provider of intelligent content management and business process automation — has been named a Strong Performer in The Forrester Wave™: Content Platforms, Q1 2023. Laserfiche was one of 13 vendors evaluated on the strength of its strategy and current offering. Laserfiche earned the highest rating possible in seven criteria: Packaged Applications Search Lifecycle Management Developer Resources App Design/Development Tools Commercial Model Intelligent document extraction According to the report, “Laserfiche has successfully transitioned its 30-plus-year track record in content management into a modern SaaS platform with a well-balanced set of services to deliver a very broad range of vertical and horizontal apps. Its product vision focuses on deeper integration of analytics, structured data sources, and AI/ML, prioritized to align to the needs of its well-defined verticals.” The report also states, “Organizations, including larger enterprises, looking for a S
Q4 Inc. Ranks on The Globe and Mail’s Women Lead Here Benchmark of Executive Gender Diversity24.3.2023 16:15:00 EET | Press release
Q4 Inc. (TSX: QFOR) (“Q4” or “the Company”), a leading capital markets communications platform provider, is proud to announce it has been included on The Globe and Mail’s 2023 Report on Business magazine’s Women Lead Here list. This annual editorial benchmark identifies top-notch Canadian businesses with the highest executive gender diversity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230324005019/en/ The Executive Women Leaders of Q4 Inc. - Pictured from left to right are Dorothy Arturi, CPO; Lorie Coulombe, SVP, Marketing & Communications; and Donna de Winter, CFO & COO. (Photo: Business Wire) This benchmark was established in 2020 by Report on Business magazine and applies a proprietary research methodology to determine Canadian corporations with the highest degree of gender diversity among executive ranks. The ranking companies have made tangible and organizational progress related to executive gender parity. “I am
ClickHouse, Inc. and Alibaba Cloud Announce a New Partnership24.3.2023 16:00:00 EET | Press release
Today, ClickHouse, Inc., creators of ClickHouse online analytical processing (OLAP) database, and Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, announced a partnership that will enable Alibaba Cloud to offer ClickHouse as an enterprise, first-party service on its platform. This partnership is an exclusive agreement between ClickHouse, Inc. and Alibaba Cloud in mainland China to offer a joint first-party enterprise service in APAC. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230324005222/en/ Aaron Katz, Founder & CEO, ClickHouse, Inc. (Photo: Business Wire) ClickHouse is the world's fastest and most resource-efficient analytical database, and since it was released as an open-source project in 2016, adoption has grown exponentially – globally. Organisations large and small benefit from the blazing fast speed - with peak processing performance for a single query standing at more than two t
Westlake Epoxy Promoting NEW AZURES™ Systems24.3.2023 13:00:00 EET | Press release
Westlake Corporation (NYSE: WLK) today announced that Westlake Epoxy will launch its new AZURES™ product range at the European Coatings Show 2023, to be held in Nuremberg, Germany, March 28 to 30, 2023. Westlake Epoxy’s Azures™ products are newly developed epoxy resins, modifiers and curing agents that are free of any SVHC- and CMR-labelled substances. As such, they provide better sustainable alternatives to existing technologies used in coatings, civil engineering and adhesives while keeping the same level of performance. “This is definitely another important milestone in Westlake Epoxy’s strategy to contribute to a safer and cleaner world,” said Ann Frederix, Vice President, Westlake Epoxy. Recently, Westlake Epoxy’s European business also confirmed its receipt of the 2022 Platinum Medal from EcoVadis, the world’s largest and most trusted provider of business sustainability ratings, and Westlake Epoxy’s Pernis, Netherlands site has successfully passed the audit for its International
Fischbein International and Votech Expand Manufacturing Footprint in Reusel and Announce New Company Name as Votech, a Duravant Company24.3.2023 11:00:00 EET | Press release
Votech announced today the grand opening of their newly expanded manufacturing facility and company headquarters in Reusel, The Netherlands. This marks the completed integration of two renowned leaders in the packaging industry, Fischbein International and Votech, who came together in 2021 through the acquisition of Votech by Duravant, a global engineered equipment and automation solutions provider to the Food Processing, Packaging and Material Handling sectors. The merger brought together 100+ years of packaging expertise and created a portfolio of technologies that expands the company’s ability to serve customers across a wide array of end markets including agriculture, animal nutrition, fruits and vegetables, ingredients, milk powders and other industrials. Alongside this announcement, the company unveiled their new company logo and brand campaign that reflects the organization’s transformation into a full-line packaging equipment provider. “The names Fischbein, Saxon and Votech, al
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom